EUVIMEDEUVIMED entdecken
Crossref

Therapeutic effects and mechanisms of isoxanthohumol on DSS-induced colitis: regulating T cell development, restoring gut microbiota, and improving metabolic disorders

Ya-Na Yang, Bing Han, Mao-Qing Zhang, Na-Nan Chai, Feng-Lin Yu, Wen-Hui Qi, Meng-Yuan Tian, Dong-Zhi Sun, Ying Huang, Qing-Xin Song, Yan Li, Mao-Cui Zhu und 2 weitere

Inflammopharmacology · 2024

DOI: 10.1007/s10787-024-01472-5 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Inflammopharmacology, 2024. Verfasst von Ya-Na Yang und 13 weiteren Autor:innen. Beteiligte Einrichtung: Key Laboratory of Medicinal Resources and Natural Pharmaceutical Chemistry (Shaanxi Normal University), The Ministry of Education, College of Life Sc…. Hauptthemen laut MEDLINE: Gastrointestinal Microbiome, Xanthones, Dextran Sulfate, Colitis. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 65 Literaturangaben. Gefördert von: National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Ulcerative colitis (UC) is a severe hazard to human health. Since pathogenesis of UC is still unclear, current therapy for UC treatment is far from optimal. Isoxanthohumol (IXN), a prenylflavonoid from hops and beer, possesses anti-microbial, anti-oxidant, anti-inflammatory, and anti-angiogenic properties. However, the potential effects of IXN on the alleviation of colitis and the action of the mechanism is rarely studied. Here, we found that administration of IXN (60 mg/kg/day, gavage) significantly attenuated dextran sodium sulfate (DSS)-induced colitis, evidenced by reduced DAI scores and histological improvements, as well as suppressed the pro-inflammatory Th17/Th1 cells but promoted the anti-inflammatory Treg cells. Mechanically, oral IXN regulated T cell development, including inhibiting CD4+ T cell proliferation, promoting apoptosis, and regulating Treg/Th17 balance. Furthermore, IXN relieved colitis by restoring gut microbiota disorder and increasing gut microbiota diversity, which was manifested by maintaining the ratio of Firmicutes/Bacteroidetes balance, promoting abundance of Bacteroidetes and Ruminococcus, and suppressing abundance of proteobacteria. At the same time, the untargeted metabolic analysis of serum samples showed that IXN promoted the upregulation of D-( +)-mannose and L-threonine and regulated pyruvate metabolic pathway. Collectively, our findings revealed that IXN could be applied as a functional food component and served as a therapeutic agent for the treatment of UC.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Gastrointestinal MicrobiomeXanthonesDextran SulfateColitisMice, Inbred C57BLAnimalsMiceMaleMetabolic DiseasesColitis, UlcerativeT-Lymphocytes, RegulatoryT-LymphocytesTh17 CellsAnti-Inflammatory AgentsDisease Models, Animal

Stichwörter der Autor:innen

Gut microbiotaIsoxanthohumolMetabolomicsPrenylflavonoidT cell developmentUlcerative colitis

Substanzen

isoxanthohumolXanthonesDextran SulfateAnti-Inflammatory Agents

Autor:innen und Institutionen

  • Key Laboratory of Medicinal Resources and Natural Pharmaceutical Chemistry (Shaanxi Normal University), The Ministry of Education, College of Life Sciences, Shaanxi Normal University, Xi'an, 710119, Shaanxi, China.
  • Key Laboratory of Medicinal Resources and Natural Pharmaceutical Chemistry (Shaanxi Normal University), The Ministry of Education, College of Life Sciences, Shaanxi Normal University, Xi'an, 710119, Shaanxi, China. yuan…
  • Key Laboratory of Medicinal Resources and Natural Pharmaceutical Chemistry (Shaanxi Normal University), The Ministry of Education, College of Life Sciences, Shaanxi Normal University, Xi'an, 710119, Shaanxi, China. xing…

Förderung

  • National Natural Science Foundation of China

Zitieren

APA

Yang, Y. N., Han, B., Zhang, M. Q., Chai, N. N., Yu, F. L., Qi, W. H., Tian, M. Y., Sun, D. Z., Huang, Y., Song, Q. X., Li, Y., Zhu, M. C., Zhang, Y., & Li, X. (2024). Therapeutic effects and mechanisms of isoxanthohumol on DSS-induced colitis: regulating T cell development, restoring gut microbiota, and improving metabolic disorders. Inflammopharmacology. https://doi.org/10.1007/s10787-024-01472-5

Vancouver

Yang YN, Han B, Zhang MQ, Chai NN, Yu FL, Qi WH, et al. Therapeutic effects and mechanisms of isoxanthohumol on DSS-induced colitis: regulating T cell development, restoring gut microbiota, and improving metabolic disorders. Inflammopharmacology. 2024. doi:10.1007/s10787-024-01472-5

BibTeX
@article{Yang2024,
  author = {Yang, Ya-Na and Han, Bing and Zhang, Mao-Qing and Chai, Na-Nan and Yu, Feng-Lin and Qi, Wen-Hui and Tian, Meng-Yuan and Sun, Dong-Zhi and Huang, Ying and Song, Qing-Xin and Li, Yan and Zhu, Mao-Cui and Zhang, Yuan and Li, Xing},
  title = {Therapeutic effects and mechanisms of isoxanthohumol on DSS-induced colitis: regulating T cell development, restoring gut microbiota, and improving metabolic disorders},
  journal = {Inflammopharmacology},
  year = {2024},
  doi = {10.1007/s10787-024-01472-5}
}
Kostenlos starten →